These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16469271)

  • 1. Challenges for gene therapy for muscular dystrophy.
    Mendell JR; Clark KR
    Curr Neurol Neurosci Rep; 2006 Jan; 6(1):47-56. PubMed ID: 16469271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress towards gene therapy for Duchenne muscular dystrophy.
    Hauser MA; Chamberlain JS
    J Endocrinol; 1996 Jun; 149(3):373-8. PubMed ID: 8691095
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of an ultrasound-mediated nucleic acid delivery system for treating muscular dystrophies].
    Negishi Y; Hamano N; Shiono H; Akiyama S; Endo-Takahashi Y; Suzuki R; Maruyama K; Aramaki Y
    Yakugaku Zasshi; 2012; 132(12):1383-8. PubMed ID: 23208045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for muscular dystrophy - a review of promising progress.
    Gregorevic P; Chamberlain JS
    Expert Opin Biol Ther; 2003 Aug; 3(5):803-14. PubMed ID: 12880380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligonucleotide-mediated gene therapy for muscular dystrophies.
    Rando TA
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S55-60. PubMed ID: 12206797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress and prospects of gene therapy clinical trials for the muscular dystrophies.
    Bengtsson NE; Seto JT; Hall JK; Chamberlain JS; Odom GL
    Hum Mol Genet; 2016 Apr; 25(R1):R9-17. PubMed ID: 26450518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micro-Dystrophin Gene Therapy Goes Systemic in Duchenne Muscular Dystrophy Patients.
    Duan D
    Hum Gene Ther; 2018 Jul; 29(7):733-736. PubMed ID: 29463117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV-based gene therapies for the muscular dystrophies.
    Crudele JM; Chamberlain JS
    Hum Mol Genet; 2019 Oct; 28(R1):R102-R107. PubMed ID: 31238336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV-directed muscular dystrophy gene therapy.
    Tang Y; Cummins J; Huard J; Wang B
    Expert Opin Biol Ther; 2010 Mar; 10(3):395-408. PubMed ID: 20132060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developments in gene therapy for muscular dystrophy.
    Hartigan-O'Connor D; Chamberlain JS
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):223-38. PubMed ID: 10679969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy of muscular dystrophy.
    Chamberlain JS
    Hum Mol Genet; 2002 Oct; 11(20):2355-62. PubMed ID: 12351570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meeting Report: 2022 Muscular Dystrophy Association Summit on 'Safety and Challenges in Gene Transfer Therapy'.
    Lek A; Atas E; Hesterlee SE; Byrne BJ; Bönnemann CG
    J Neuromuscul Dis; 2023; 10(3):327-336. PubMed ID: 36806515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies.
    Cordier L; Gao GP; Hack AA; McNally EM; Wilson JM; Chirmule N; Sweeney HL
    Hum Gene Ther; 2001 Jan; 12(2):205-15. PubMed ID: 11177557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral vectors for gene transfer of micro-, mini-, or full-length dystrophin.
    Scott JM; Li S; Harper SQ; Welikson R; Bourque D; DelloRusso C; Hauschka SD; Chamberlain JS
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S23-9. PubMed ID: 12206791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for muscular disease.
    Johnston N
    Drug Discov Today; 2004 Sep; 9(18):777. PubMed ID: 15364061
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene therapy in Duchenne muscular dystrophy.
    Inui K; Okada S; Dickson G
    Brain Dev; 1996; 18(5):357-61. PubMed ID: 8891229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy.
    Duan D
    Mol Ther; 2018 Oct; 26(10):2337-2356. PubMed ID: 30093306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for muscular dystrophies: current status and future prospects.
    Takeda S; Miyagoe-Suzuki Y
    BioDrugs; 2001; 15(10):635-44. PubMed ID: 11604045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy prospects for Duchenne muscular dystrophy.
    Clemens PR; Caskey CT
    Eur Neurol; 1994; 34(4):181-5. PubMed ID: 8082675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for muscular dystrophy: molecular medicines entering the clinic.
    Bushby K; Lochmüller H; Lynn S; Straub V
    Lancet; 2009 Nov; 374(9704):1849-56. PubMed ID: 19944865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.